However, these neuroendocrine pathways are easily overwhelmed by the use of insulin analogues and/or secretagogues, leading to inadvertent hypoglycemia and the clinical syndrome of hypoglycemia-associated autonomic failure (HAAF) (Cryer, 2005). Here, INS is linked to Hypoglycemia.